IPSEN (IPN.PA) Stock Fundamental Analysis

EPA:IPN • FR0010259150

157.7 EUR
-0.5 (-0.32%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

IPN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 52 industry peers in the Pharmaceuticals industry. IPN has an excellent financial health rating, but there are some minor concerns on its profitability. IPN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • IPN had positive earnings in the past year.
  • IPN had a positive operating cash flow in the past year.
  • IPN had positive earnings in each of the past 5 years.
  • Each year in the past 5 years IPN had a positive operating cash flow.
IPN.PA Yearly Net Income VS EBIT VS OCF VS FCFIPN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • IPN's Return On Assets of 11.21% is fine compared to the rest of the industry. IPN outperforms 78.85% of its industry peers.
  • With a Return On Equity value of 17.93%, IPN perfoms like the industry average, outperforming 59.62% of the companies in the same industry.
  • The Return On Invested Capital of IPN (21.54%) is better than 86.54% of its industry peers.
Industry RankSector Rank
ROA 11.21%
ROE 17.93%
ROIC 21.54%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPN.PA Yearly ROA, ROE, ROICIPN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • IPN has a Profit Margin of 13.25%. This is comparable to the rest of the industry: IPN outperforms 53.85% of its industry peers.
  • In the last couple of years the Profit Margin of IPN has declined.
  • Looking at the Operating Margin, with a value of 25.32%, IPN is in line with its industry, outperforming 59.62% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IPN has remained more or less at the same level.
  • The Gross Margin of IPN (81.66%) is better than 86.54% of its industry peers.
  • IPN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.32%
PM (TTM) 13.25%
GM 81.66%
OM growth 3Y-3.38%
OM growth 5Y-1.48%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
IPN.PA Yearly Profit, Operating, Gross MarginsIPN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • IPN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for IPN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IPN.PA Yearly Shares OutstandingIPN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
IPN.PA Yearly Total Debt VS Total AssetsIPN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • IPN has an Altman-Z score of 4.94. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
  • IPN's Altman-Z score of 4.94 is fine compared to the rest of the industry. IPN outperforms 73.08% of its industry peers.
  • The Debt to FCF ratio of IPN is 1.18, which is an excellent value as it means it would take IPN, only 1.18 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 1.18, IPN belongs to the best of the industry, outperforming 90.38% of the companies in the same industry.
  • IPN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of IPN (0.19) is better than 73.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.18
Altman-Z 4.94
ROIC/WACC2.65
WACC8.13%
IPN.PA Yearly LT Debt VS Equity VS FCFIPN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.96 indicates that IPN should not have too much problems paying its short term obligations.
  • IPN has a better Current ratio (1.96) than 71.15% of its industry peers.
  • IPN has a Quick Ratio of 1.79. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
  • IPN has a Quick ratio of 1.79. This is amongst the best in the industry. IPN outperforms 82.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.79
IPN.PA Yearly Current Assets VS Current LiabilitesIPN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 125.29%, which is quite impressive.
  • IPN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.10% yearly.
  • Looking at the last year, IPN shows a very strong growth in Revenue. The Revenue has grown by 64.12%.
  • Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 7.90% on average per year.
EPS 1Y (TTM)125.29%
EPS 3Y-11.98%
EPS 5Y-4.1%
EPS Q2Q%289.23%
Revenue 1Y (TTM)64.12%
Revenue growth 3Y7.57%
Revenue growth 5Y7.9%
Sales Q2Q%115.57%

3.2 Future

  • Based on estimates for the next years, IPN will show a small growth in Earnings Per Share. The EPS will grow by 2.92% on average per year.
  • Based on estimates for the next years, IPN will show a small growth in Revenue. The Revenue will grow by 2.69% on average per year.
EPS Next Y0.62%
EPS Next 2Y2.1%
EPS Next 3Y4.86%
EPS Next 5Y2.92%
Revenue Next Year3.73%
Revenue Next 2Y4.64%
Revenue Next 3Y5.11%
Revenue Next 5Y2.69%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IPN.PA Yearly Revenue VS EstimatesIPN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
IPN.PA Yearly EPS VS EstimatesIPN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • IPN is valuated correctly with a Price/Earnings ratio of 16.92.
  • Compared to the rest of the industry, the Price/Earnings ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 69.23% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.99. IPN is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 13.83, IPN is valued correctly.
  • IPN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IPN is cheaper than 75.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of IPN to the average of the S&P500 Index (28.06), we can say IPN is valued rather cheaply.
Industry RankSector Rank
PE 16.92
Fwd PE 13.83
IPN.PA Price Earnings VS Forward Price EarningsIPN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • IPN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IPN is cheaper than 94.23% of the companies in the same industry.
  • 75.00% of the companies in the same industry are more expensive than IPN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.96
EV/EBITDA 6.01
IPN.PA Per share dataIPN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)27.16
PEG (5Y)N/A
EPS Next 2Y2.1%
EPS Next 3Y4.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.95%, IPN is not a good candidate for dividend investing.
  • IPN's Dividend Yield is comparable with the industry average which is at 1.91.
  • Compared to an average S&P500 Dividend Yield of 1.85, IPN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.95%

5.2 History

  • The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
IPN.PA Yearly Dividends per shareIPN.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 14.95% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
  • IPN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP14.95%
EPS Next 2Y2.1%
EPS Next 3Y4.86%
IPN.PA Yearly Income VS Free CF VS DividendIPN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M
IPN.PA Dividend Payout.IPN.PA Dividend Payout, showing the Payout Ratio.IPN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IPSEN

EPA:IPN (2/20/2026, 7:00:00 PM)

157.7

-0.5 (-0.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)07-29
Inst Owners15.35%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap13.22B
Revenue(TTM)5.87B
Net Income(TTM)777.50M
Analysts69.47
Price Target135.82 (-13.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.95%
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP14.95%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.97%
PT rev (3m)3.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.8%
EPS NY rev (3m)3.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 16.92
Fwd PE 13.83
P/S 2.25
P/FCF 15.96
P/OCF 11.43
P/B 3.05
P/tB 9.35
EV/EBITDA 6.01
EPS(TTM)9.32
EY5.91%
EPS(NY)11.41
Fwd EY7.23%
FCF(TTM)9.88
FCFY6.26%
OCF(TTM)13.8
OCFY8.75%
SpS70
BVpS51.74
TBVpS16.87
PEG (NY)27.16
PEG (5Y)N/A
Graham Number104.16
Profitability
Industry RankSector Rank
ROA 11.21%
ROE 17.93%
ROCE 27.02%
ROIC 21.54%
ROICexc 29.88%
ROICexgc 113.42%
OM 25.32%
PM (TTM) 13.25%
GM 81.66%
FCFM 14.11%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.38%
OM growth 5Y-1.48%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.18
Debt/EBITDA 0.4
Cap/Depr 52.58%
Cap/Sales 5.6%
Interest Coverage 250
Cash Conversion 54.79%
Profit Quality 106.48%
Current Ratio 1.96
Quick Ratio 1.79
Altman-Z 4.94
F-Score7
WACC8.13%
ROIC/WACC2.65
Cap/Depr(3y)123.84%
Cap/Depr(5y)123.25%
Cap/Sales(3y)11.93%
Cap/Sales(5y)11.8%
Profit Quality(3y)111.08%
Profit Quality(5y)104.31%
High Growth Momentum
Growth
EPS 1Y (TTM)125.29%
EPS 3Y-11.98%
EPS 5Y-4.1%
EPS Q2Q%289.23%
EPS Next Y0.62%
EPS Next 2Y2.1%
EPS Next 3Y4.86%
EPS Next 5Y2.92%
Revenue 1Y (TTM)64.12%
Revenue growth 3Y7.57%
Revenue growth 5Y7.9%
Sales Q2Q%115.57%
Revenue Next Year3.73%
Revenue Next 2Y4.64%
Revenue Next 3Y5.11%
Revenue Next 5Y2.69%
EBIT growth 1Y87.65%
EBIT growth 3Y3.94%
EBIT growth 5Y6.31%
EBIT Next Year24.19%
EBIT Next 3Y10.15%
EBIT Next 5Y4.57%
FCF growth 1Y522.48%
FCF growth 3Y4.75%
FCF growth 5Y5.6%
OCF growth 1Y26.34%
OCF growth 3Y5.92%
OCF growth 5Y8.44%

IPSEN / IPN.PA FAQ

What is the fundamental rating for IPN stock?

ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.


What is the valuation status of IPSEN (IPN.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for IPSEN?

IPSEN (IPN.PA) has a profitability rating of 6 / 10.


What is the financial health of IPSEN (IPN.PA) stock?

The financial health rating of IPSEN (IPN.PA) is 7 / 10.


How sustainable is the dividend of IPSEN (IPN.PA) stock?

The dividend rating of IPSEN (IPN.PA) is 3 / 10 and the dividend payout ratio is 14.95%.